MedPath

Examination of safety and efficacy of pulmonary rehabilitation for patients with pulmonary hypertension: Appropriate exercise prescription on pulmonary hypertension during exercise

Phase 2
Recruiting
Conditions
pulmonary hypertension
Registration Number
JPRN-jRCT1030210240
Lead Sponsor
Sugiura Toshihiko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
21
Inclusion Criteria

1) Patients diagnosed with pulmonary hypertension (resting mPAP of 20 mmHg or more by right heart catheterization)
2) Patients who have already been treated with vasodilators for pulmonary hypertension and have not changed their treatment for more than 3 months
3) Patients with resting mPAP < 35 mmHg and PVR not increased by more than 15% compared with the previous right heart catheterization.
4) Patients who underwent a cardiopulmonary exercise stress test during the previous right heart catheterization
5) Patients aged 20 years or older at the time of consent.
6) Patients who have received sufficient explanation for participation in the study and have given written consent of their own free will with sufficient understanding.

Exclusion Criteria

1) Patients with poorly controlled heart failure, heart disease, or arrhythmia
2) Patients with osteoarticular diseases or neuromuscular diseases that affect ADL
3) Patients with mental illness or cognitive decline that makes it difficult to perform the test safely and accurately

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath